Small compounds. A bigger picture.
Explore eight familiar cannabinoids and their connections to symptoms, conditions and treatment research. CBD is one cannabinoid—not a name for all of them.
The connection atlas
Choose a cannabinoid. Follow the evidence.
Cannabidiol
Not typically intoxicatingOne cannabinoid, not an umbrella term for all of them. Prescription purified CBD and retail CBD oils or gummies are not interchangeable.
A connection means research exists—not that this cannabinoid is a remedy. Solid lines: specific prescription approval. Dashed lines: other evidence.
CBD Evidence, not promises
Specific seizure disorders
What the research says
Epidiolex (purified prescription CBD) is FDA-approved for seizures associated with Lennox–Gastaut syndrome, Dravet syndrome and tuberous sclerosis complex in patients aged 1 year and older. This does not establish approval for every seizure type or retail CBD.
Treatment context
A neurologist may consider prescription cannabidiol for Lennox–Gastaut syndrome, Dravet syndrome or tuberous sclerosis complex. Do not replace or stop antiseizure medication with retail CBD.
CBD: important cautions
CBD can cause liver injury, sleepiness and medication interactions. Prescription treatment may require liver monitoring; retail products can be mislabeled or contain THC.
Check the source
FDA · Approved medicines & product limitsHow to read this map
Specific Rx approved
U.S. FDA approval applies to a named prescription medicine and a specific condition—not retail cannabis products.
Limited human evidence
Human studies exist, but findings may be modest, mixed or preliminary. This is not a treatment recommendation.
Lab / animal research
Findings in cells or animals do not establish that a treatment works in people.
Insufficient evidence
Research does not establish a reliable benefit for this compound and condition.
Selected examples, not an exhaustive cannabinoid catalog, systematic review or personalized recommendation. A missing connection means it is not covered here—not proof of benefit or harm. U.S. prescription approvals are shown; rules and approvals differ by country.
Safety comes first
This is education, not diagnosis or a treatment plan. Review cannabinoid use with a qualified clinician or pharmacist, especially with other medicines or liver disease. Avoid cannabis and CBD during pregnancy or breastfeeding, and do not give them to children without specialist care. Do not drive while impaired or combine sedating products with alcohol. Nonprescription products are not equivalent to studied medicines.
Sources & further reading
Each connection links to its supporting source. Research evolves; early findings may not be confirmed.
For educational purposes only. This content is not medical advice and has not been evaluated by the FDA.